SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000920465-19-000131
Filing Date
2019-09-18
Accepted
2019-09-18 16:17:32
Documents
4
Period of Report
2019-09-18
Effectiveness Date
2019-09-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A proxy2019.htm DEF 14A 763763
2 image1a07.jpg GRAPHIC 164429
3 lajolla2019proxycard9181001.jpg GRAPHIC 215345
4 lajolla2019proxycard9181002.jpg GRAPHIC 129722
  Complete submission text file 0000920465-19-000131.txt   1466741
Mailing Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121
Business Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36282 | Film No.: 191099934
SIC: 2836 Biological Products, (No Diagnostic Substances)